Shigeo Koido Selected Research

Carcinoma (Carcinomatosis)

3/2013	Prognostic impact of expression of Bcl-2 and Bax genes in circulating immune cells derived from patients with head and neck carcinoma.
2/2013	Characterization of structure and direct antigen presentation by dendritic/tumor-fused cells as cancer vaccines.
10/2011	Induction of cytotoxic T lymphocytes against ovarian cancer-initiating cells.
11/2005	Assessment of fusion cells from patient-derived ovarian carcinoma cells and dendritic cells as a vaccine for clinical use.
6/2003	Immunotherapy of spontaneous mammary carcinoma with fusions of dendritic cells and mucin 1-positive carcinoma cells.
2/2003	Prevention of spontaneous breast carcinoma by prophylactic vaccination with dendritic/tumor fusion cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shigeo Koido Research Topics

Disease

64	Neoplasms (Cancer) 03/2020 - 02/2003
20	Pancreatic Neoplasms (Pancreatic Cancer) 11/2020 - 06/2010
16	Wilms Tumor (Wilm's Tumor) 10/2020 - 09/2013
7	Adenocarcinoma 11/2021 - 10/2015
6	Breast Neoplasms (Breast Cancer) 07/2015 - 02/2003
6	Carcinoma (Carcinomatosis) 03/2013 - 02/2003
5	Ulcerative Colitis 01/2021 - 05/2013
5	Hypersensitivity (Allergy) 01/2019 - 02/2014
5	Colorectal Neoplasms (Colorectal Cancer) 05/2016 - 11/2005
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019 - 10/2010
3	Crohn Disease (Crohn's Disease) 01/2019 - 05/2013
3	Neoplasm Metastasis (Metastasis) 01/2015 - 01/2012
2	Necrosis 01/2022 - 01/2015
2	Fever (Fevers) 01/2021 - 09/2013
2	Squamous Cell Carcinoma of Head and Neck 01/2014 - 07/2013
2	Ovarian Neoplasms (Ovarian Cancer) 10/2011 - 01/2010
2	Residual Neoplasm 01/2009 - 09/2007
2	Hepatocellular Carcinoma (Hepatoma) 09/2008 - 08/2007
1	Granuloma 01/2022
1	Dysbiosis 01/2019
1	Constipation 01/2019
1	Infections 01/2019
1	Human Influenza (Influenza) 01/2019
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2019
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2019
1	Glioma (Gliomas) 12/2016
1	Glioblastoma (Glioblastoma Multiforme) 12/2016
1	Hemorrhage 05/2016
1	Varicose Veins (Varicose Vein) 05/2016
1	Stomach Neoplasms (Stomach Cancer) 05/2016
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 10/2015

Drug/Important Bio-Agent (IBA)

34	AntigensIBA 03/2020 - 12/2004
27	VaccinesIBA 03/2020 - 02/2003
21	Cancer VaccinesIBA 01/2019 - 02/2003
17	Peptides (Polypeptides)IBA 10/2020 - 01/2010
10	Gemcitabine FDA Link 01/2018 - 01/2011
6	Neoplasm Antigens (Tumor Antigens)IBA 09/2019 - 12/2004
6	Proteins (Proteins, Gene)FDA Link 07/2019 - 01/2013
6	PicibanilIBA 01/2018 - 01/2007
4	Interleukin-12 (IL 12)IBA 02/2016 - 04/2002
4	Mucin-1 (CA 15-3 Antigen)IBA 08/2014 - 02/2003
3	AcidsIBA 01/2022 - 05/2013
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2014
3	HLA Antigens (Human Leukocyte Antigens)IBA 10/2020 - 05/2013
3	Messenger RNA (mRNA)IBA 07/2019 - 09/2011
3	Combined VaccinesIBA 01/2018 - 07/2013
3	EpitopesIBA 01/2015 - 08/2014
3	HLA-DR Antigens (HLA-DR)IBA 01/2015 - 06/2010
3	Fluorouracil (Carac)FDA LinkGeneric 11/2014 - 06/2010
3	Transforming Growth Factors (Transforming Growth Factor)IBA 08/2013 - 01/2013
3	Heat-Shock Proteins (Heat-Shock Protein)IBA 07/2013 - 01/2010
3	HLA-A*02:01 antigenIBA 05/2013 - 12/2004
3	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2012 - 02/2003
3	Carcinoembryonic AntigenIBA 09/2008 - 11/2005
2	Metronidazole (Metric)FDA LinkGeneric 01/2021 - 01/2014
2	Tetracycline (Achromycin)FDA LinkGeneric 01/2021 - 01/2014
2	Amoxicillin (Wymox)FDA LinkGeneric 01/2021 - 01/2014
2	Small Interfering RNA (siRNA)IBA 07/2019 - 01/2015
2	WT1 ProteinsIBA 08/2018 - 02/2014
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2018 - 05/2013
2	Chondroitin Sulfates (Chondroitin Sulfate)IBA 06/2017 - 01/2015
2	SulfotransferasesIBA 06/2017 - 01/2015
2	CarbohydratesIBA 06/2017 - 01/2015
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 12/2016 - 02/2013
2	InterleukinsIBA 10/2015 - 01/2014
2	Ado-Trastuzumab EmtansineIBA 10/2015 - 07/2015
2	MucinsIBA 10/2015 - 06/2003
2	Protein Subunit VaccinesIBA 12/2013 - 05/2013
2	Ethanol (Ethyl Alcohol)IBA 08/2013 - 01/2013
2	HLA-A Antigens (HLA-A)IBA 05/2013 - 03/2007
2	Interleukin-10 (Interleukin 10)IBA 01/2013 - 06/2010
2	Penicillins (Penicillin)FDA Link 01/2013 - 01/2007
1	Immunologic Factors (Immunomodulators)IBA 11/2021
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 09/2019
1	MicroRNAs (MicroRNA)IBA 07/2019
1	OligonucleotidesIBA 07/2019
1	25-hydroxyvitamin DIBA 01/2019
1	16S Ribosomal RNAIBA 01/2019
1	Vitamin D FDA LinkGeneric 01/2019
1	PrebioticsIBA 01/2019
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	ParaffinIBA 12/2016
1	Temozolomide (Temodar)FDA LinkGeneric 12/2016
1	Interleukin-6 (Interleukin 6)IBA 10/2015
1	Monoclonal AntibodiesIBA 10/2015
1	Immunoglobulins (Immunoglobulin)IBA 10/2015
1	Galectins (Galectin)IBA 10/2015
1	Immune Checkpoint InhibitorsIBA 10/2015
1	Immune Checkpoint ProteinsIBA 10/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 07/2015
1	Cytotoxins (Cytolysins)IBA 07/2015

Therapy/Procedure

17	Drug Therapy (Chemotherapy) 11/2020 - 01/2011
17	Immunotherapy 09/2019 - 06/2003
13	Therapeutics 01/2021 - 06/2010
2	Immunomodulation 01/2018 - 09/2014
2	Radiotherapy 07/2013 - 07/2013
1	Fecal Microbiota Transplantation 01/2019
1	Gastrectomy 05/2016
1	Sclerotherapy 05/2016